Next Article in Journal
Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents
Next Article in Special Issue
Structure-Activity Relationship Study of Sesquiterpene Lactones and Their Semi-Synthetic Amino Derivatives as Potential Antitrypanosomal Products
Previous Article in Journal
Synthesis, Spectroscopic and Theoretical Studies of New Quasi-Podands from Bile Acid Derivatives Linked by 1,2,3-Triazole Rings
Previous Article in Special Issue
Antileishmanial Lead Structures from Nature: Analysis of Structure-Activity Relationships of a Compound Library Derived from Caffeic Acid Bornyl Ester
Molecules 2014, 19(2), 2571-2587; doi:10.3390/molecules19022571
Article

Synthetic Fosmidomycin Analogues with Altered Chelating Moieties Do Not Inhibit 1-Deoxy-D-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum Growth In Vitro

1
, 1
, 2
, 3
, 2
, 4
, 3
 and 1,*
Received: 6 February 2014; in revised form: 18 February 2014 / Accepted: 19 February 2014 / Published: 24 February 2014
View Full-Text   |   Download PDF [387 KB, uploaded 18 June 2014]   |   Browse Figures
Abstract: Fourteen new fosmidomycin analogues with altered metal chelating groups were prepared and evaluated for inhibition of E. coli Dxr, M. tuberculosis Dxr and the growth of P. falciparum K1 in human erythrocytes. None of the synthesized compounds showed activity against either enzyme or the Plasmodia. This study further underlines the importance of the hydroxamate functionality and illustrates that identifying effective alternative bidentate ligands for this target enzyme is challenging.
Keywords: fosmidomycin; DOXP reductoisomerase; non-mevalonate pathway; isoprenoid biosynthesis; coordination chemistry fosmidomycin; DOXP reductoisomerase; non-mevalonate pathway; isoprenoid biosynthesis; coordination chemistry
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Chofor, R.; Risseeuw, M.D.; Pouyez, J.; Johny, C.; Wouters, J.; Dowd, C.S.; Couch, R.D.; Van Calenbergh, S. Synthetic Fosmidomycin Analogues with Altered Chelating Moieties Do Not Inhibit 1-Deoxy-D-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum Growth In Vitro. Molecules 2014, 19, 2571-2587.

AMA Style

Chofor R, Risseeuw MD, Pouyez J, Johny C, Wouters J, Dowd CS, Couch RD, Van Calenbergh S. Synthetic Fosmidomycin Analogues with Altered Chelating Moieties Do Not Inhibit 1-Deoxy-D-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum Growth In Vitro. Molecules. 2014; 19(2):2571-2587.

Chicago/Turabian Style

Chofor, René; Risseeuw, Martijn D.; Pouyez, Jenny; Johny, Chinchu; Wouters, Johan; Dowd, Cynthia S.; Couch, Robin D.; Van Calenbergh, Serge. 2014. "Synthetic Fosmidomycin Analogues with Altered Chelating Moieties Do Not Inhibit 1-Deoxy-D-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum Growth In Vitro." Molecules 19, no. 2: 2571-2587.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert